Searches for “GLP-1” Surpass “Ozempic” as Patients Shift to Drug Class Research, Says Sagapixel | Martech Edge | Best News on Marketing and Technology
GFG image
Searches for “GLP-1” Surpass “Ozempic” as Patients Shift to Drug Class Research, Says Sagapixel

digital marketing

Searches for “GLP-1” Surpass “Ozempic” as Patients Shift to Drug Class Research, Says Sagapixel

Searches for “GLP-1” Surpass “Ozempic” as Patients Shift to Drug Class Research, Says Sagapixel

GlobeNewswire

Published on : Jun 2, 2025

Digital marketing agency Sagapixel reveals a pivotal change in how patients research weight loss medications: public searches for “GLP-1” have overtaken those for “Ozempic.” This transition, reflecting an informed consumer base seeking drug class information rather than brand names, signals important shifts for healthcare providers and marketers in the evolving weight loss medication landscape.

1. Key Data Insights on Search Trends

  • As of Q1 2025, monthly searches for “GLP-1” exceed 3 million, surpassing “Ozempic,” which declined from its early 2024 peak of 6 million.

  • This indicates patients’ growing understanding of GLP-1 receptor agonists as a drug category rather than focusing on individual brands.

2. Impact of Legal Pressures on Marketing

  • Legal challenges from Novo Nordisk forced providers to remove “semaglutide” mentions, complicating organic SEO for this term.

  • The rise of “GLP-1” as a safer, high-volume keyword offers new opportunities for providers to connect with patients effectively.

3. Drivers Behind the GLP-1 Search Growth

  • Extensive mass media advertising by companies like Hims and Ro, with significant marketing budgets.

  • Social media influencers and major publications (Vogue, Men’s Health, The New York Times) amplifying awareness.

  • Consumer confusion over newer drugs such as Zepbound and tirzepatide leading to comparative searches.

  • Clinics shifting marketing focus to “GLP-1 weight loss programs” instead of brand-specific promotions.

4. Recommended Provider Marketing Strategies

  • Shift messaging to emphasize the GLP-1 drug class rather than individual brands.

  • Optimize SEO and advertising for broad class-level keywords like “GLP-1 injections near me.”

  • Develop compliant, educational content that guides patients through weight loss medication options, building trust and authority.

Sagapixel’s data signals a fundamental shift in patient search behavior toward a more educated, comparison-driven audience seeking information on GLP-1 medications as a class. Providers who pivot their marketing and SEO strategies accordingly will not only meet patient expectations but also position themselves for growth in a competitive digital landscape.

Contact Us & Future-Proof Your Marketing with MarTechEdge!